Effects of statins on thrombosis development in patients with systemic lupus erythematosus and antiphospholipid antibodies

Serious Infections Among Adult Medicaid Beneficiaries With Systemic Lupus Erythematosus and Lupus Nephritis

(2015) Candace H. Feldman et al.   Arthritis & Rheumatology

14th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends

(2014) Doruk Erkan et al.   AUTOIMMUNITY REVIEWS

A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients

(2013) Doruk Erkan et al.   ANNALS OF THE RHEUMATIC DISEASES

Statin treatment and the risk of recurrent pulmonary embolism

(2013) S. Biere-Rafi et al.   EUROPEAN HEART JOURNAL

Use of Glucocorticoids and Risk of Venous Thromboembolism

(2013) Sigrun A. Johannesdottir et al.   JAMA Internal Medicine

Efficacy and safety of statins in the prevention of atherosclerosis in patients with systemic lupus erythematosus — A meta-analysis of randomized controlled trials

(2012) Yicong Ye et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome

(2010) C. Lopez-Pedrera et al.   ANNALS OF THE RHEUMATIC DISEASES

Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies

(2009) Maria G. Tektonidou et al.   ARTHRITIS AND RHEUMATISM

Update of the guidelines for lupus anticoagulant detection

(2009) V. PENGO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism

(2009) Robert J. Glynn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort

(2008) R Kaiser et al.   ANNALS OF THE RHEUMATIC DISEASES